REFERENCES
1. Iskratsch T, Wolfenson H, Sheetz MP. Appreciating force and shape-the rise of mechanotransduction in cell biology. Nat Rev Mol Cell Biol. 2014;15:825-33.
2. Mammoto T, Ingber DE. Mechanical control of tissue and organ development. Development. 2010;137:1407-20.
4. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310:1139-43.
5. DuFort CC, Paszek MJ, Weaver VM. Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol. 2011;12:308-19.
6. Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol. 2014;15:802-12.
7. Tanaka K, Joshi D, Timalsina S, Schwartz MA. Early events in endothelial flow sensing. Cytoskeleton (Hoboken). 2021;78:217-31.
8. Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009;10:75-82.
9. Belaadi N, Aureille J, Guilluy C. Under pressure: mechanical stress management in the nucleus. Cells. 2016;5:27.
13. Mashek DG. Hepatic lipid droplets: a balancing act between energy storage and metabolic dysfunction in NAFLD. Mol Metab. 2021;50:101115.
14. Scorletti E, Carr RM. A new perspective on NAFLD: focusing on lipid droplets. J Hepatol. 2022;76:934-45.
15. Seebacher F, Zeigerer A, Kory N, Krahmer N. Hepatic lipid droplet homeostasis and fatty liver disease. Semin Cell Dev Biol. 2020;108:72-81.
17. Hammoutene A, Rautou PE. Role of liver sinusoidal endothelial cells in nonalcoholic fatty liver disease. J Hepatol. 2019;70:1278-91.
18. Long Y, Niu Y, Liang K, Du Y. Mechanical communication in fibrosis progression. Trends Cell Biol. 2022;32:70-90.
19. Ma H, Liu X, Zhang M, Niu J. Liver sinusoidal endothelial cells are implicated in multiple fibrotic mechanisms. Mol Biol Rep. 2021;48:2803-15.
20. Zhu C, Tabas I, Schwabe RF, Pajvani UB. Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis. Nat Rev Gastroenterol Hepatol. 2021;18:131-42.
21. Chen G, Xia B, Fu Q, et al. Matrix mechanics as regulatory factors and therapeutic targets in hepatic fibrosis. Int J Biol Sci. 2019;15:2509-21.
22. Park S, Chen Y. Mechanics of biological systems. In. Introduction to mechanobiology and experimental techniques: Morgan & Claypool Publishers; 2019. Available from: https://iopscience.iop.org/book/mono/978-1-64327-392-1.pdf [Last accessed on 16 Mar 2023].
23. Verdier C, Etienne J, Duperray A, Preziosi L. Review: rheological properties of biological materials. Comptes Rendus Physique. 2009;10:790-811.
24. Park S, Jung WH, Pittman M, Chen J, Chen Y. The effects of stiffness, fluid viscosity, and geometry of microenvironment in homeostasis, aging, and diseases: a brief review. J Biomech Eng. 2020:142.
25. Charrier EE, Pogoda K, Wells RG, Janmey PA. Control of cell morphology and differentiation by substrates with independently tunable elasticity and viscous dissipation. Nat Commun. 2018;9:449.
26. Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatology. 2008;47:1394-400.
27. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269-339.
28. Poisson J, Lemoinne S, Boulanger C, et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol. 2017;66:212-27.
29. Mönkemöller V, Øie C, Hübner W, Huser T, McCourt P. Multimodal super-resolution optical microscopy visualizes the close connection between membrane and the cytoskeleton in liver sinusoidal endothelial cell fenestrations. Sci Rep. 2015;5:16279.
30. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125-72.
31. Baffy G. Kupffer cells in nonalcoholic fatty liver disease: the emerging view. J Hepatol. 2009;51:212-23.
32. Cromar GL, Xiong X, Chautard E, Ricard-Blum S, Parkinson J. Toward a systems level view of the ECM and related proteins: a framework for the systematic definition and analysis of biological systems. Proteins. 2012;80:1522-44.
33. Duscher D, Maan ZN, Wong VW, et al. Mechanotransduction and fibrosis. J Biomech. 2014;47:1997-2005.
34. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol. 2003;200:504-15.
35. Gong Z, Szczesny SE, Caliari SR, et al. Matching material and cellular timescales maximizes cell spreading on viscoelastic substrates. Proc Natl Acad Sci USA. 2018;115:E2686-95.
37. Tamaki N, Kurosaki M, Huang DQ, Loomba R. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Hepatol Res. 2022;52:497-507.
38. Sharma AK, Reis J, Oppenheimer DC, et al. Attenuation of shear waves in normal and steatotic livers. Ultrasound Med Biol. 2019;45:895-901.
39. Sugimoto K, Moriyasu F, Oshiro H, et al. Clinical utilization of shear wave dispersion imaging in diffuse liver disease. Ultrasonography. 2020;39:3-10.
40. Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022-30.
41. Poul SS, Parker KJ. Fat and fibrosis as confounding cofactors in viscoelastic measurements of the liver. Phys Med Biol. 2021;66:045024.
42. Pearson A, Dujardin PA, d’Alteroche L, et al. Vibration-controlled transient elastography for noninvasive evaluation of liver steatosis. Med Phys. 2022;49:1507-21.
43. Parker KJ, Ormachea J. The quantification of liver fat from wave speed and attenuation. Phys Med Biol. 2021;66:145011.
45. Shoham N, Girshovitz P, Katzengold R, Shaked NT, Benayahu D, Gefen A. Adipocyte stiffness increases with accumulation of lipid droplets. Biophys J. 2014;106:1421-31.
46. Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86-112.
47. Ijaz S, Yang W, Winslet MC, Seifalian AM. Impairment of hepatic microcirculation in fatty liver. Microcirculation. 2003;10:447-56.
48. Wada K, Fujimoto K, Fujikawa Y, Shibayama Y, Mitsui H, Nakata K. Sinusoidal stenosis as the cause of portal hypertension in choline deficient diet induced fatty cirrhosis of the rat liver. Acta Pathol Jpn. 1974;24:207-17.
49. Yoshihara H, Hijioka T, Eguchi H, et al. Hepatic microcirculatory disturbance in fatty liver as a cause of portal hypertension. J Gastroenterol Hepatol. 1989;4 Suppl 1:279-81.
50. Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol. 2017;14:343-55.
51. Faulkner CS, White CM, Shah VH, Jophlin LL. A single nucleotide polymorphism of PLIN2 is associated with nonalcoholic steatohepatitis and causes phenotypic changes in hepatocyte lipid droplets: a pilot study. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865:158637.
52. Romero LM, Dickens MJ, Cyr NE. The Reactive Scope Model - a new model integrating homeostasis, allostasis, and stress. Horm Behav. 2009;55:375-89.
53. Liu YL, Reeves HL, Burt AD, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with nonalcoholic fatty liver disease. Nat Commun. 2014;5:4309.
54. Li R, Bu Y, Yang C, Wang J. Effects of lipid deposition on viscoelastic response in human hepatic cell line HepG2. Front Physiol. 2021;12:684121.
55. Baldini F, Bartolozzi A, Ardito M, et al. Biomechanics of cultured hepatic cells during different steatogenic hits. J Mech Behav Biomed Mater. 2019;97:296-305.
56. Zhang X, Gao X, Zhang P, et al. Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. Med Eng Phys. 2017;44:79-86.
57. Parker KJ. A microchannel flow model for soft tissue elasticity. Phys Med Biol. 2014;59:4443-57.
58. Parker KJ, Ormachea J, Drage MG, Kim H, Hah Z. The biomechanics of simple steatosis and steatohepatitis. Phys Med Biol. 2018;63:105013.
59. Caldwell S, Ikura Y, Dias D, et al. Hepatocellular ballooning in NASH. J Hepatol. 2010;53:719-23.
60. Ogawa S, Moriyasu F, Yoshida K, et al. Relationship between liver tissue stiffness and histopathological findings analyzed by shear wave elastography and compression testing in rats with nonalcoholic steatohepatitis. J Med Ultrason (2001). 2016;43:355-60.
61. Seifalian AM, Piasecki C, Agarwal A, Davidson BR. The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation. 1999;68:780-4.
62. Balci A, Karazincir S, Sumbas H, Oter Y, Egilmez E, Inandi T. Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics. J Clin Ultrasound. 2008;36:134-40.
63. Li N, Zhang X, Zhou J, et al. Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer. Adv Drug Deliv Rev. 2022;188:114448.
64. Francque S, Verrijken A, Mertens I, et al. Noncirrhotic human nonalcoholic fatty liver disease induces portal hypertension in relation to the histological degree of steatosis. Eur J Gastroenterol Hepatol. 2010;22:1449-57.
65. Pasarín M, La Mura V, Gracia-Sancho J, et al. Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. PLoS One. 2012;7:e32785.
66. Miyao M, Kotani H, Ishida T, et al. Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. Lab Invest. 2015;95:1130-44.
67. Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 1963;44:239-42.
68. Shah V, Haddad FG, Garcia-Cardena G, et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest. 1997;100:2923-30.
69. Francque S, Laleman W, Verbeke L, et al. Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture. Lab Invest. 2012;92:1428-39.
70. Hilscher MB, Sehrawat T, Arab JP, et al. Mechanical stretch increases expression of cxcl1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension. Gastroenterology. 2019;157:193-209.e9.
71. Wisse E, Braet F, Shami GJ, et al. Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver. Histochem Cell Biol. 2022;157:27-38.
72. Labernadie A, Trepat X. Sticking, steering, squeezing and shearing: cell movements driven by heterotypic mechanical forces. Curr Opin Cell Biol. 2018;54:57-65.
74. Vogel V, Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol. 2006;7:265-75.
75. Weis K. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell. 2003;112:441-51.
76. Chatterjee S. Endothelial mechanotransduction, redox signaling and the regulation of vascular inflammatory pathways. Front Physiol. 2018;9:524.
78. Sun X, Harris EN. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease. Am J Physiol Cell Physiol. 2020;318:C1200-13.
79. Angulo-Urarte A, van der Wal T, Huveneers S. Cell-cell junctions as sensors and transducers of mechanical forces. Biochim Biophys Acta Biomembr. 2020;1862:183316.
80. Zamir E, Geiger B. Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci. 2001;114:3583-90.
81. Wang Y, Jin G, Miao H, Li JY, Usami S, Chien S. Integrins regulate VE-cadherin and catenins: dependence of this regulation on Src, but not on Ras. Proc Natl Acad Sci USA. 2006;103:1774-9.
82. Rooij J, Kerstens A, Danuser G, Schwartz MA, Waterman-Storer CM. Integrin-dependent actomyosin contraction regulates epithelial cell scattering. J Cell Biol. 2005;171:153-64.
83. Zuidema A, Wang W, Sonnenberg A. Crosstalk between cell adhesion complexes in regulation of mechanotransduction. Bioessays. 2020;42:e2000119.
84. Sosa BA, Rothballer A, Kutay U, Schwartz TU. LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. Cell. 2012;149:1035-47.
85. Guilluy C, Osborne LD, Van Landeghem L, et al. Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus. Nat Cell Biol. 2014;16:376-81.
86. Matsuda A, Mofrad MRK. On the nuclear pore complex and its emerging role in cellular mechanotransduction. APL Bioeng. 2022;6:011504.
87. Dupont S, Morsut L, Aragona M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474:179-83.
88. Halder G, Dupont S, Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol. 2012;13:591-600.
89. Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811-28.
90. Mo JS, Yu FX, Gong R, Brown JH, Guan KL. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev. 2012;26:2138-43.
91. Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell. 2016;29:783-803.
92. Pocaterra A, Romani P, Dupont S. YAP/TAZ functions and their regulation at a glance. J Cell Sci. 2020;133:jcs230425.
93. Martino F, Perestrelo AR, Vinarský V, Pagliari S, Forte G. Cellular mechanotransduction: from tension to function. Front Physiol. 2018;9:824.
94. Desai SS, Tung JC, Zhou VX, et al. Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha. Hepatology. 2016;64:261-75.
95. Greuter T, Yaqoob U, Gan C, et al. Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. J Hepatol. 2022;77:723-34.
96. Urushima H, Yuasa H, Matsubara T, et al. Activation of hepatic stellate cells requires dissociation of e-cadherin-containing adherens junctions with hepatocytes. Am J Pathol. 2021;191:438-53.
97. Li W, Li P, Li N, et al. Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model. Am J Physiol Gastrointest Liver Physiol. 2021;320:G272-82.
98. Song Z, Gupta K, Ng IC, Xing J, Yang YA, Yu H. Mechanosensing in liver regeneration. Semin Cell Dev Biol. 2017;71:153-67.
99. Ishikawa J, Takeo M, Iwadate A, et al. Mechanical homeostasis of liver sinusoid is involved in the initiation and termination of liver regeneration. Commun Biol. 2021;4:409.
100. Mitten EK, Baffy G. Mechanotransduction in the pathogenesis of nonalcoholic fatty liver disease. J Hepatol. 2022;77:1642-56.
101. Van der Graaff D, Kwanten WJ, Couturier FJ, et al. Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats. Lab Invest. 2018;98:1263-75.
102. García-Lezana T, Raurell I, Bravo M, et al. Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis. Hepatology. 2018;67:1485-98.
103. Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models. Hepatol Int. 2018;12:1-10.
104. Puoti C, Bellis L. Steatosis and portal hypertension. Eur Rev Med Pharmacol Sci. 2005;9:285-90.
106. Baffy G, Bosch J. Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: Is it real and how to measure it? J Hepatol. 2022;76:458-63.
107. Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci. 2000;45:196-200.
108. Tarantino G, Citro V, Balsano C. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2021;15:759-69.
109. Mendes FD, Suzuki A, Sanderson SO, Lindor KD, Angulo P. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012;10:1028-33.e2.
110. Rodrigues SG, Montani M, Guixé-Muntet S, De Gottardi A, Berzigotti A, Bosch J. Patients with signs of advanced liver disease and clinically significant portal hypertension do not necessarily have cirrhosis. Clin Gastroenterol Hepatol. 2019;17:2101-2109.e1.
111. Lei L, Ei Mourabit H, Housset C, Cadoret A, Lemoinne S. Role of angiogenesis in the pathogenesis of NAFLD. J Clin Med. 2021;10:1338.
112. Coulon S, Francque S, Colle I, et al. Evaluation of inflammatory and angiogenic factors in patients with nonalcoholic fatty liver disease. Cytokine. 2012;59:442-9.
113. Coulon S, Legry V, Heindryckx F, et al. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology. 2013;57:1793-805.
